Medical writing support, under the direction of the authors, was provided by Eric Comeau, Ph.D., of CMC Connect, McCann Health Medical Communications and was funded by Pfizer Inc., New York, NY, USA, in accordance with Good Publication Practice (GPP3) guidelines (Ann Intern Med 2015;163:461464).
Aleksandar Petrov, MD | Updated: July 2026 Last Updated: July 14, 2026 A Retatrutide 4mg dose refers to one of the higher amounts that has been examined in published research on this investigational compound, generally appearing later in a studys range of tested levels
Once reconstituted with bacteriostatic water, keep the solution refrigerated and use within the timeframe outlined in your research protocol
Not for human use or direct consumer application